The pharmacokinetic profile of ARCT-810 was favorable, and preliminary data shows that no ARCT-810 lipid was detectable in the plasma beyond 48 hours following drug administration.

LUNAR® lipids undetectable in plasma 48 hours following drug administration. ARCT-810 well tolerated at doses up to 0.3 mg/kg, 0.4 mg/kg cohort to be completed in Q4 ...

Researchers have found that that a mutant strain of sake yeast produces high levels of the amino acid ornithine. Ornithine has been found to reduce fatigue and improve sleep quality, and the non ...

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver ...